EcoDrugPlus

Alpha-Amylase 2b-Like

Ensembl ID : ENSBBBG00000001457
Gene Symbol: LOC104981711
2 Cross references
199 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSBBBG00000000843
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSBBBG00000021254
Gene Symbol: APCS
3 Cross references
402 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSBBBG00000002542
Gene Symbol: APP
3 Cross references
279 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSBBBG00000013491
Gene Symbol: ACE
1 Cross references
92 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSBBBG00000007578
Gene Symbol: AGTR1
1 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSBBBG00000017747
Gene Symbol: AGTR2
3 Cross references
195 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSBBBG00000023500
Gene Symbol: APH1A
3 Cross references
138 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSBBBG00000010302
Gene Symbol: APH1B
2 Cross references
193 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSBBBG00000010846
Gene Symbol: APEX1
3 Cross references
207 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSBBBG00000003259
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSBBBG00000009611
Gene Symbol: ALOX5
3 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).